GLP-1-based therapies helped adults with overweight or obesity lose weight mainly by reducing fat mass and visceral adipose ...

In the battle of the obesity bulge, glucagon-like peptide-1 receptor agonist medications — aka GLP-1s such as Wegovy and Zepbound — have changed the game for some people who’ve struggled to lose ...

New reserach suggests that msucle loss with GLP-1s may not be as high as previously thought. Bloomberg/Getty Images Past studies show that adults taking a GLP-1 medication can lose between 5-15% of ...

Here are the signs of muscle loss and what you can do to maintain your strength.

Smart exercise choices and adequate nutrition will help preserve muscle and the metabolic benefits that come with it ...

With more than 15 million Americans taking GLP-1 medications like Ozempic, Wegovy and Mounjaro, experts say patients could lose more than just fat if they aren't careful."The key to weight loss and ...

MANY MEN STARTING GLP-1 medications like semaglutide or tirzepatide are trying to lose visceral fat. I’ve seen this in my work with clients as a dietitian. And targeting visceral fat is a good thing.

Share on Pinterest Scientists have found that an antibody treatment prevented a decline in muscle mass and bone density after using GLP-1 drugs. Rob and Julia Campbell/Stocksy Aging and limited ...

Fat, not skeletal muscle, accounted for most of the weight loss. According to the study, GLP-1 medicines reduced body fat in obese mice much more than lean body mass, and fat and liver mass fell ...

Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists—and the physicians who treat them—should not be worried about the muscle loss that occurs alongside what’s often rapid weight loss ...